SEC Info - APP Pharmaceuticals, Inc. - ‘S-3’ on 9/5/03

SEC Info℠

Home

Help

Please Sign In

APP Pharmaceuticals, Inc. – ‘S-3’ on 9/5/03 – EX-12.1

On: Friday, 9/5/03, at 4:55pm ET · Accession #: 1193125-3-46127 · File #: 333-108553

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/05/03  APP Pharmaceuticals, Inc.         S-3                    5:828K                                   RR Donnelley/FA

Registration Statement for Securities Offered Pursuant to a Transaction — Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Registration Statement for Securities Offered       HTML    442K 
                          Pursuant to a Transaction                              
 2: EX-4.2      Form of Indenture                                     94    413K 
 3: EX-5.1      Opinion of Morrison & Foerster LLP                  HTML     10K 
 4: EX-12.1     Computations of Ratio of Earnings to Fixed Charges  HTML     39K 
 5: EX-23.2     Consent of Ernst and Young LLP                      HTML      6K

EX-12.1 — Computations of Ratio of Earnings to Fixed Charges

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Computations of ratio of earnings to fixed charges

Exhibit 12.1

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

	Year Ended December 31,												Six Months Ended June 30,
	1998(1)			1999		2000			2001		2002		2002		2003
	(in thousands, except ratio)
Ratio of Earnings to Fixed Charges
Earnings
Income (loss) before income taxes and equity in net income (loss) of Drug Source Co., LLC	$	(801	)	$	10,229	$	(13,675	)	$	20,753	$	76,633	$	28,100	$	61,998
Add:
Interest expense		1,256			2,104		1,751			4,419		1,358		721		6
Loan fee amortization		29			128		129			900		851		425		426
Amortization of capitalized interest		—			—		—			23		23		11		11

Earnings	$	484		$	12,461	$	(11,795	)	$	26,095	$	78,865	$	29,257	$	62,441

Fixed charges
Interest expense	$	1,256		$	2,104	$	1,751		$	4,419	$	1,358	$	721	$	6
Capitalized interest		—			27		226			—		—		—		—
Loan fee amortization		29			128		129			900		851		425		426
Preferred stock dividend (1)		912			1,680		1,574			1,668		—		—		—

Fixed charges	$	2,197		$	3,939	$	3,680		$	6,987	$	2,209	$	1,146	$	432

Ratio of Earnings to Fixed Charges		0.22			3.16		(3.21	)		3.73		35.70		25.53		144.54

(1)

The preferred stock dividend is the amount of the dividend divided by one less the effective income tax rate.

Dates Referenced Herein

This ‘S-3’ Filing	Date	Other Filings

Filed on:	9/5/03	None on these Dates
	6/30/98
		List all Filings

↑Top

Filing Submission 0001193125-03-046127 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)